SCHEMBL30522145

SCHEMBL30522145

Cc1c(NC(=O)c2cc(C3CC3)c(C=O)cn2)cccc1-c1cccc(NC(=O)c2cc(C3CC3)c(C=O)cn2)c1C

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PDCD1 Q15116 20/20 0.67
▸ CD274 Q9NZQ7 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22769812 1.00 PDCD1 (0.67) PDCD1CD274
SCHEMBL24446140 0.96 PDCD1 (0.64) PDCD1CD274
SCHEMBL22675462 0.94 PDCD1 (0.61) PDCD1CD274
SCHEMBL24446142 0.91 PDCD1 (0.58) PDCD1CD274
SCHEMBL24446650 0.91 PDCD1 (0.73) PDCD1CD274
SCHEMBL24446157 0.86 PDCD1 (0.57) PDCD1CD274
SCHEMBL28783906 0.85 PDCD1 (0.53) PDCD1CD274
SCHEMBL30112620 0.83 PDCD1 (0.64) PDCD1CD274
SCHEMBL22769791 0.83 PDCD1 (0.64) PDCD1CD274
SCHEMBL22769830 0.83 PDCD1 (0.78) PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3750887-B1 BIARYL DERIVATIVES AND THEIR PHARMACEUTICAL APPLICATION FOR THE TREATMENT OF PD-1/PD-L1 SIGNAL PATHWAY-MEDIATED DISEASES ABBISKO THERAPEUTICS CO LTD (CN) 2025-05-28 — — EP disclosed
WO-2023169373-A1 HOLOSYMMETRIC BIPHENYL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海和誉生物医药科技有限公司 2023-09-14 — — WO disclosed
Send feedback